Maria Teresa B. Abola

Author

Also Known As

Abola, Maria Teresa, I. Spelt, Lauren Kay Evangelista, M T Abola, M.-T.-B. Abola, M.T. Abola, MARIA TERESA ABOLA, Maria Teresa Abola, Maria Teresa B Abola, Maria Teresa B. Abola

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Brigham and Women's Hospital Philippine Heart Center Harvard University University of Edinburgh Hamilton Health Sciences

About

Maria Teresa B. Abola is an author at Brigham and Women's Hospital specializing in cardiovascular disease, medicine, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	2.8K
2	Public Health	4	4	784
3	Emergency Medicine	4	4	1.3K
4	Epidemiology	4	4	784
5	Global Health	1	1	14

Maria Teresa B. Abola

Publications

Citations

H-Index

Page 1

	Year	Citations
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial Sonia S. Anand, Jackie Bosch, John W. Eikelboom, The Lancet ThrombosisCardiovascular DiseaseStrokeMedicinePlacebo-controlled Trial	2017	855
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial Stuart J. Connolly, John W. Eikelboom, Jackie Bosch, The Lancet ThrombosisCardiovascular DiseaseAtherosclerosisMedicineCoronary Artery Disease	2017	749
Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease Sonia S. Anand, François Caron, John W. Eikelboom, Journal of the American College of Cardiology ThrombosisVascular DiseaseCardiovascular DiseasePeripheral Artery DiseaseArterial Disease	2018	438
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease Marc P. Bonaca, Deepak L. Bhatt, Robert F. Storey, Journal of the American College of Cardiology ThrombosisHeart FailureCardiovascular DiseaseAtherosclerosisMedicine	2016	383
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry P. Cacoub, Maria Teresa B. Abola, Iris Baumgärtner, Atherosclerosis ThrombosisContinued HealthCardiovascular EpidemiologyHealth PolicyCardiovascular Disease	2008	248
Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: Data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry Iris Baumgärtner, Alan T. Hirsch, Maria Teresa B. Abola, Journal of Vascular Surgery ThrombosisVascular DiseaseCardiovascular Risk ProfileCardiovascular EpidemiologyCardiovascular Disease	2008	84
Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease Eric Kaplovitch, John W. Eikelboom, Leanne Dyal, JAMA Cardiology	2020	78
Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease: A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee Maria Teresa B. Abola, Jonathan Golledge, Tetsuro Miyata, Journal of Atherosclerosis and Thrombosis	2020	74
Fate of individuals with ischemic amputations in the REACH Registry: Three-year cardiovascular and limb-related outcomes Maria Teresa B. Abola, Deepak L. Bhatt, Sue Duval, Atherosclerosis Ischemic SyndromeAmputationLimb ReconstructionCardiovascular DiseaseIschemic Amputations	2012	59
Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54 Remo H.M. Furtado, José Carlos Nicolau, Giulia Magnani, European Heart Journal	2019	37

Page 1